OpenAccess: Closed

This work is not Open Acccess. We may still have a PDF, if this is the case there will be a green box below.

Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)

Daniel Castellano,Jaume Capdevila,Javier Sastre,Vicente Alonso,Marta Llanos,Rocío García‐Carbonero,José Luis Manzano Mozo,Isabel Sevilla,Ignacio Durán,Ramón Salazar

Sorafenib

Bevacizumab

Medicine

2013

Cite this:

Generate Citation

“Sorafenib and bevacizumab combination targeted therapy in advanced neuroendocrine tumour: A phase II study of Spanish Neuroendocrine Tumour Group (GETNE0801)” is a paper by Daniel Castellano Jaume Capdevila Javier Sastre Vicente Alonso Marta Llanos Rocío García‐Carbonero José Luis Manzano Mozo Isabel Sevilla Ignacio Durán Ramón Salazar published in 2013. It has an Open Access status of “closed”. You can read and download a PDF Full Text of this paper here.